Skip to content
Nerac
  • Home
  • About
    • About Us
    • How to Engage
    • Meet Our Team
    • Case Studies
  • Services
    • Commercialization Services
    • Critical Updates
    • Diligence & Risk Mitigation
    • Intellectual Property
    • Market Research
    • Medical Device Regulatory
    • Technology Scouting
  • Who We Serve
    Life Sciences
    • Biotech & Pharma
    • Med Devices & Diagnostics
    • Clinical Research
    • Healthcare Systems
    • Regulatory Affairs
    Learn More
    Advanced Materials
    • Advanced Materials
    • Metals & Treatments
    • 3D Printing
    • Smart Materials
    • Manufacturing Systems
    Learn More
    Engineering
    • Chemical
    • Mechanical
    • Electrical & Electronics
    • Aerospace & Defense
    • Energy Systems
    • Consumer & Industrial
    Learn More
    Tech & Innovation
    • Semiconductors
    • Green Tech
    • Photonics & Optics
    • Lab & Analytical Tools
    • Software, AI & Data-Driven Solutions
    Learn More
    Business & Compliance
    • IP & Strategy
    • Sustainability
    • Device & Drug Regulation
    • Risk & Compliance
    Learn More
  • Insights

    our most recent article

    View All Articles
    • Bridging EU MDR and FDA QMSR: A Unified Approach to Post-Market Surveillance

      Medical device manufacturers operating globally face a growing challenge: post-market surveillance systems that satisfy EU MDR requirements do not automatically meet FDA expectations under the new QMSR.

      Read More

    Browse By Topic

    • All
    • Advanced Materials
    • Commercialization Strategy
    • Critical Alerts
    • Innovation
    • Intellectual Property
    • Market Research
    • Medical Device
    • Patent Strategy
    • Regulatory
    • Sustainability
    • Tech Scouting
  • Contact Us
Schedule a Consultation
Nerac
  • Home
  • About
    • About Us
    • How to Engage
    • Meet Our Team
    • Case Studies
  • Services
    • Commercialization Services
    • Critical Updates
    • Diligence & Risk Mitigation
    • Intellectual Property
    • Market Research
    • Medical Device Regulatory
    • Technology Scouting
  • Who We Serve
    Life Sciences
    • Biotech & Pharma
    • Med Devices & Diagnostics
    • Clinical Research
    • Healthcare Systems
    • Regulatory Affairs
    Learn More
    Advanced Materials
    • Advanced Materials
    • Metals & Treatments
    • 3D Printing
    • Smart Materials
    • Manufacturing Systems
    Learn More
    Engineering
    • Chemical
    • Mechanical
    • Electrical & Electronics
    • Aerospace & Defense
    • Energy Systems
    • Consumer & Industrial
    Learn More
    Tech & Innovation
    • Semiconductors
    • Green Tech
    • Photonics & Optics
    • Lab & Analytical Tools
    • Software, AI & Data-Driven Solutions
    Learn More
    Business & Compliance
    • IP & Strategy
    • Sustainability
    • Device & Drug Regulation
    • Risk & Compliance
    Learn More
  • Insights

    our most recent article

    View All Articles
    • Bridging EU MDR and FDA QMSR: A Unified Approach to Post-Market Surveillance

      Medical device manufacturers operating globally face a growing challenge: post-market surveillance systems that satisfy EU MDR requirements do not automatically meet FDA expectations under the new QMSR.

      Read More

    Browse By Topic

    • All
    • Advanced Materials
    • Commercialization Strategy
    • Critical Alerts
    • Innovation
    • Intellectual Property
    • Market Research
    • Medical Device
    • Patent Strategy
    • Regulatory
    • Sustainability
    • Tech Scouting
  • Contact Us

Regulatory

  1. Home
  2. Regulatory
  • All
  • Advanced Materials
  • Commercialization Strategy
  • Critical Alerts
  • Innovation
  • Intellectual Property
  • Market Research
  • Medical Device
  • Patent Strategy
  • Regulatory
  • Sustainability
  • Tech Scouting
  • Software as a Medical Device: Regulatory Framework

    April 29, 2025

    The regulatory framework for Software as a Medical Device (SaMD) ensures that software intended for medical purposes is safe and effective for patient use. This includes assessing risks, validating clinical effectiveness, and adhering to stringent cybersecurity standards. Navigating these regulations is critical to bringing SaMD products to market successfully.

    Read Article
  • Software as a Medical Device: Regulator’s Challenge

    April 15, 2025

    Discover how Software as a Medical Device (SaMD) is transforming healthcare—and the regulatory complexities that come with it. This article explores key challenges, evolving global standards, and the role of AI and machine learning in SaMD development.

    Read Article
  • Utilizing Clinical Information for QMSR Compliance and Product Improvement

    February 5, 2025

    Starting February 2, 2026, the FDA will require all medical devices sold in the U.S. to comply with the new Quality Management System Regulation (QMSR), aligning with ISO 13485:2016. This update emphasizes a risk-based approach to product compliance, ensuring enhanced safety and efficacy. Clinical data will play a crucial role in meeting these standards by guiding design improvements, risk management, and regulatory submissions.

    Read Article
  • EUDR and the Butterfly Effect; EU’s challenge

    June 25, 2024

    The European Union’s Regulation on Deforestation-Free Products (EUDR) is expected to impact many consumer products across the global supply chain.

    Read Article
  • Literature and Data Appraisal in Clinical Evaluation Reports

    April 5, 2024

    Substantiating the safety and performance of your medical device is the most important part of bringing a medical device to market. In the European Union (EU), the clinical evaluation report (CER) is a major component of this process.

    Read Article
  • Medical Device Post-Market Surveillance in the EU: PMCF, PMSR, and PSUR

    February 29, 2024

    In the European Union (EU), post-market surveillance is a crucial phase of a medical device's regulatory compliance. Learn about the three components of this framework that ensure manufacturers are properly capturing, documenting, and reporting this phase of the product lifecycle.

    Read Article
  • Clinical Literature Reviews for Regulatory Submissions: Not Just for the EU

    January 12, 2024

    This article outlines the importance of systematic clinical literatures for achieving and maintaining regulatory compliance, most notably in the EU but also in other markets, which may have differing literature review requirements.

    Read Article
  • NGS Assays: Here are the Variables of Clinical Performance

    October 6, 2023

    Since the early 2000s next-generation sequencing (NGS Assays) has become an invaluable tool in both drug discovery research and clinical/diagnostic settings.

    Read Article
  • Pediatric Medical Devices – Confronting Innovation Challenges

    October 5, 2023

    Pediatric medical devices are critical for proper medical care of children. The connection between innovation and realization is a challenging one.

    Read Article
12Next

For over 60 years, Nerac has delivered research and advisory services that reduce risk, accelerate product development, and drive market success for global innovators.

Customer Access

Find Us On:

Quick Links

  • Home
  • About Us
  • How to Engage
  • Insights
  • Glossary
  • Resources
  • Contact Us
  • Schedule A Consultation

Services

  • Commercialization Services
  • Critical Updates
  • Diligence & Risk Mitigation
  • Intellectual Property
  • Market Research
  • Medical Device Regulatory
  • Technology Scouting

Contact Information

  • 225 Oakland Rd,
    Suite 402
    South Windsor, CT 06074
    United States
  • info@nerac.com

  • (860) 872-7000

© 2026 Nerac | All Rights Reserved | Privacy Policy | Terms & Conditions | AI Policy

Website & Marketing by NetVisits

Take The First Step Today!
Page load link
Go to Top